{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:31:23Z","timestamp":1696591883202},"reference-count":49,"publisher":"The Fukushima Society of Medical Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fukushima J. Med. Sci.","FJMS"],"published-print":{"date-parts":[[2003]]},"DOI":"10.5387\/fms.49.55","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T23:53:30Z","timestamp":1389225210000},"page":"55-67","source":"Crossref","is-referenced-by-count":7,"title":["HISTOGENESIS OF CD5-POSITIVE AND CD5-NEGATIVE B-CELL NEOPLASMS ON THE ASPECT OF SOMATIC MUTATION OF IMMUNOGLOBULIN HEAVY CHAIN GENE VARIABLE REGION"],"prefix":"10.5387","volume":"49","author":[{"given":"NAOYA","family":"NAKAMURA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAFUMI","family":"ABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tonegawa S. Somatic generation of antibody diversity. Nature, 302<\/b>: 575-581, 1983.","DOI":"10.1038\/302575a0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rajewsky K. Clonal selection and learning in the antibody system. Nature, 381<\/b>: 751-758, 1996.","DOI":"10.1038\/381751a0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell, 90<\/b>: 1073-1083, 1997.","DOI":"10.1016\/S0092-8674(00)80373-6"},{"key":"4","unstructured":"4. Nussenzweig MC. Immune receptor editing: revise and select. Cell, 95<\/b>: 875-878, 1998."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan IC. Mechanism of antigen-driven selection in germinal centers. Nature, 342<\/b>: 929-931, 1989.","DOI":"10.1038\/342929a0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jacob J, Kelsoe G, Rajewsky K, Weiss U. Intraclonal generation of antibody mutants in germinal centers. Nature, 354<\/b>: 389-392, 1991.","DOI":"10.1038\/354389a0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Berek C, Ziegner M. The maturation of immune response. Immunol Today, 14<\/b>: 400-404, 1993.","DOI":"10.1016\/0167-5699(93)90143-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today, 16<\/b>: 237-242, 1995.","DOI":"10.1016\/0167-5699(95)80166-9"},{"key":"9","unstructured":"9. Goossens T, Klein U, Kuppers R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci USA, 95<\/b>: 2463-2468, 1998."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hikida M, Mori M, Takai T, Tomochika K, Hamatani K, Ohmori H. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science, 274<\/b>: 2092-2094, 1996.","DOI":"10.1126\/science.274.5295.2092"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Liu YJ, Arpin C, de Bouteiller O, Guret C, Banchereau J, Martinez-Valdez H, Lebecque S. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin Immunol, 8<\/b>: 169-177, 1996.","DOI":"10.1006\/smim.1996.0021"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Küppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene, 20<\/b>: 5580-5594, 2001.","DOI":"10.1038\/sj.onc.1204640"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science, 280<\/b>: 1750-1752, 1998.","DOI":"10.1126\/science.280.5370.1750"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature, 412<\/b>: 341-346, 2001.","DOI":"10.1038\/35085588"},{"key":"15","unstructured":"15. Diaz Cano S. PCR-based alternative for diagnosis of immunoglobulin heavy chain gene rearrangement: principles, practice, and polemics. Diagn Mol Pathol, 5<\/b>: 3-9, 1996."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kuze T, Nakamura N, Hashimoto Y, Abe M. Most of CD30+ anaplastic large cell lymphoma of B cell type show a somatic mutation in the IgH V region genes. Leukemia, 12<\/b>: 753-757, 1998.","DOI":"10.1038\/sj.leu.2400998"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Stewart K, Schwartz RS. Immunoglobulin V regions and the B cell. Blood, 83<\/b>: 1717-1730, 1994.","DOI":"10.1182\/blood.V83.7.1717.1717"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hayakawa K, Hardy RR, Herzenberg LA. Progenitors for Ly-1 B-cells are distinct from progenitors for other B cells. J Exp Med, 161<\/b>: 1554-1568, 1985.","DOI":"10.1084\/jem.161.6.1554"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hardy RR, Hayakawa K. Development and physiology of LY-1 B and its human homolog, Leu-1B. Immunol Rev, 93<\/b>: 53-79, 1986.","DOI":"10.1111\/j.1600-065X.1986.tb01502.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kipps TJ. The CD5 B cells. Adv Immunol, 47<\/b>: 117-185, 1989.","DOI":"10.1016\/S0065-2776(08)60663-X"},{"key":"21","unstructured":"21. Stall AM, Wells SM, Lam KP. B-1 cells: unique origin and functions. Semin Immunol, 8<\/b>: 45-59, 1996."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, Ktippers R. Somatic hypermutation in normal and transformed human B cells. Immunol Rev, 162<\/b>: 261-280, 1998.","DOI":"10.1111\/j.1600-065X.1998.tb01447.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Brezinschek HP, Foster SJ, Brezinschek RI, Dorner T, Domiati Saad R, Lipsky PE. Analysis of the human VH gene repertorie. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)\/IgM+ and CD5(−)\/IgM+ B cells. J Clin Invest, 99<\/b>: 2488-2501, 1997.","DOI":"10.1172\/JCI119433"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Munakata Y, Saito S, Hoshino A, Muryoi T, Hirabayashi Y, Shibata S, Miura T, Ishii T, Funato T, Sasaki T. Somatic mutation in autoantibody-associated VH genes of circulating IgM+ IgD+ cells. Eur J Immunol, 28<\/b>: 1435-1444, 1998.","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1435::AID-IMMU1435>3.0.CO;2-R"},{"key":"25","unstructured":"25. Burns BF, Warnke RA, Doggett RS, RousRV. Expression of a T-cell antigen (Leu-1) by B-cell lymphoma. Am J Patho l, 113<\/b>: 165-171, 1983."},{"key":"26","unstructured":"26. Knowles DM, Halper JP, Azzo W, Wang CY. Reactivity of monoclonal antibodies Leu 1 and OKTl with malignant human lymphoid cells: correlation with conventional cell markers. Cancer, 52<\/b>: 1369-1377, 1983."},{"key":"27","unstructured":"27. Zukerberg LR, Medeiros LJL, Ferry JA, Harris NL. Diffuse low-grade B-cell lymphomas: four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol, 100<\/b>: 373-385, 1993."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Oscier DG, Thompsett A, Zhu D, Stevenson FK. Differential rates of somatic hypermutation in VH genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood, 89<\/b>: 4153-4160, 1997.","DOI":"10.1182\/blood.V89.11.4153"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nakamura N, Kuze T, Hashimoto Y, Tasaki K, Hojo H, Sasaki Y, Sato M, Abe M. Analysis of the immunoglobulin heavy chain gene variable region of 101 cases with peripheral B-cell neoplasms in the Japanese population. Pathol International, 49<\/b>: 595-600, 1997.","DOI":"10.1046\/j.1440-1827.1999.00911.x"},{"key":"30","unstructured":"30. Caligaris-cappio F. B-chronic lymphocytic leukemia: A malignancy of anti-self B-cells. Blood, 87<\/b>: 2615-2620, 1996."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Weisenburger DD, Armitage JO. Mantle cell lymphoma— an entity comes of age. Blood, 87<\/b>: 4483-4494, 1996.","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483"},{"key":"32","unstructured":"32. Nakamura N, Hashimoto Y, Kuze T, Tasaki K, Sasaki Y, Sato M, Abe M. Analysis of the immunoglobulin heavy chain gene variable region of CD5−<\/sup> positive diffuse large B-cell lymphoma. Lab Invest, 79<\/b>: 925-933, 1999."},{"key":"33","unstructured":"33. unpublished data"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kume M, Suzuki R, Yatabe Y, Kagami Y, Miura I, Miura AB, Morishima Y, Nakamura S, Seta M. Somatic hypermutation in the VH segment of immunoglobulin genes of CD5−<\/sup> positive diffuse large B-cell lymphoma. Jpn J Cancer Res, 88<\/b>: 1087-1093, 1997.","DOI":"10.1111\/j.1349-7006.1997.tb00333.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Taniguchi M, Oka K, Hiasa A, Yamaguchi M, Ohno T, Kita K, Shiku H. De novo CD5+<\/sup> diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood, 91<\/b>: 1145-1151, 1998.","DOI":"10.1182\/blood.V91.4.1145"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Katzenberger T, Lohr A, Schwarz S, Dreyling M, Schoof J, Nickenig C, Stilgenbauer S, Kalla J, Ott MM, Muller-Hermelink HK, Ott G. Genetic analysis of de novo CD5+<\/sup> diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+<\/sup> progenitor B cell. Blood, 101<\/b>: 699-702, 2003.","DOI":"10.1182\/blood-2002-06-1726"},{"key":"37","unstructured":"37. Ikematsu W, Ikematsu H, Okamura S, Otsuka T, Harada M, Niho Y. Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5−<\/sup> chronic leukemia. Blood, 83<\/b>: 2602-2610, 1994."},{"key":"38","unstructured":"38. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med, 188<\/b>: 1679-1689, 1998."},{"key":"39","unstructured":"39. Jaffe ES, Harris NL, Stein H, Varidiman JW (eds.) World Health Organization Classification of Tumours. Tumours of Haematopoietic and Lymphoid tissues. IARC press Lyon 2002."},{"key":"40","unstructured":"40. Hojo H, Sasaki Y, Nakamura N, Abe M. Absence of somatic hypermutation of immunoglobulin heavy chain variable region genes in precursor B-lymphoblastic lymphoma: a study of four cases in childhood and adolescence. Am J Clin Pathol, 116<\/b>: 673-682, 2001."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Muller-Hermelink HK, Greiner A. Molecular analysis of human immunoglobulin heavy chain variable gene (IgVH) in normal and malignant B cells. Am J Pathol, 153<\/b>: 1341-1345, 1998.","DOI":"10.1016\/S0002-9440(10)65718-5"},{"key":"42","unstructured":"42. Bahler DW, Levy R. Clonal evolution of follicular lymphoma: Evidence for antigen selection. Proc Natl Acad Sci USA, 89<\/b>: 6770-6774, 1992."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Ki.ippers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med, 341<\/b>: 1520-1529, 1999.","DOI":"10.1056\/NEJM199911113412007"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Mullar-Hermelink HK. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood, 86<\/b>: 3528-3534, 1995.","DOI":"10.1182\/blood.V86.9.3528.bloodjournal8693528"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, Romero L, Sole F, Salida M, Florensa L, Martinez P, Campo E, Piris MA. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood, 99<\/b>: 1299-1304, 2002.","DOI":"10.1182\/blood.V99.4.1299"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Bakkus MH, Heirman C, Van Reit I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood, 80<\/b>: 2326-2335, 1992.","DOI":"10.1182\/blood.V80.9.2326.2326"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Nakamura N, Nakamine H, Tamaru J, Nakamura S, Yoshino T, Ohshima K, Abe M. The Distinction between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma with c-myc<\/i> Rearrangement. Mod Pathol, 15<\/b>: 771-776, 2002.","DOI":"10.1097\/01.MP.0000019577.73786.64"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Hecht JL, Aster JC. Molecular Biology of Burkitt's Lymphoma. J Clin Oncal, 18<\/b>: 3707-3721, 2000.","DOI":"10.1200\/JCO.2000.18.21.3707"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Ki.ippers R. Molecular biology of Hodgkin's lymphoma. Adv Cancer Res, 84<\/b>: 277-312, 2002.","DOI":"10.1016\/S0065-230X(02)84009-X"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:14:41Z","timestamp":1621538081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/49\/2\/49_55\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.49.55","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003]]}}}